ATE326451T1 - Chinazolin derivate und therapeutische verwendungen davon - Google Patents
Chinazolin derivate und therapeutische verwendungen davonInfo
- Publication number
- ATE326451T1 ATE326451T1 AT99938565T AT99938565T ATE326451T1 AT E326451 T1 ATE326451 T1 AT E326451T1 AT 99938565 T AT99938565 T AT 99938565T AT 99938565 T AT99938565 T AT 99938565T AT E326451 T1 ATE326451 T1 AT E326451T1
- Authority
- AT
- Austria
- Prior art keywords
- therapeutic uses
- quinazoline derivatives
- chymase
- quianazoline
- exacerbation
- Prior art date
Links
- JWVCLYRUEFBMGU-UHFFFAOYSA-N quinazoline Chemical class N1=CN=CC2=CC=CC=C21 JWVCLYRUEFBMGU-UHFFFAOYSA-N 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
- 102000003858 Chymases Human genes 0.000 abstract 2
- 108090000227 Chymases Proteins 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 1
- 230000005713 exacerbation Effects 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000008728 vascular permeability Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
- C07D239/96—Two oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
- C07C311/52—Y being a hetero atom
- C07C311/54—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea
- C07C311/57—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea having sulfur atoms of the sulfonylurea groups bound to carbon atoms of six-membered aromatic rings
- C07C311/60—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea having sulfur atoms of the sulfonylurea groups bound to carbon atoms of six-membered aromatic rings having nitrogen atoms of the sulfonylurea groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP23563398 | 1998-08-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE326451T1 true ATE326451T1 (de) | 2006-06-15 |
Family
ID=16988920
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99938565T ATE326451T1 (de) | 1998-08-21 | 1999-08-20 | Chinazolin derivate und therapeutische verwendungen davon |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US6867214B1 (de) |
| EP (1) | EP1114035B1 (de) |
| JP (1) | JP2002523404A (de) |
| KR (1) | KR20010089168A (de) |
| CN (1) | CN1216872C (de) |
| AT (1) | ATE326451T1 (de) |
| AU (1) | AU772771B2 (de) |
| CA (1) | CA2341357A1 (de) |
| DE (1) | DE69931378T2 (de) |
| ES (1) | ES2259476T3 (de) |
| HU (1) | HUP0103387A3 (de) |
| WO (1) | WO2000010982A1 (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2281358T3 (es) * | 1999-11-01 | 2007-10-01 | Asubio Pharma Co., Ltd. | Uso de inhibidores de quimasa contra el deposito vascular de lipidos. |
| EP1192949A4 (de) * | 2000-02-22 | 2005-11-09 | Daiichi Suntory Pharma Co Ltd | Azneimittel mit chymaseinhibitoren als wirksames mittel, zur vorbeugung oder behandlung von fibrosis |
| WO2001062294A1 (en) | 2000-02-22 | 2001-08-30 | Suntory Limited | Preventive or therapeutic drugs for dermatitises containing chymase inhibitors as the active ingredient |
| ATE352317T1 (de) | 2000-02-22 | 2007-02-15 | Daiichi Asubio Pharma Co Ltd | Therapeutische behandlung von eosinophilie durch verwendung von chymase-inhibitoren als aktiven bestandteilen |
| DE60142914D1 (de) * | 2000-09-18 | 2010-10-07 | Toa Eiyo Ltd | N-substituierte benzothiophensulfonamid-derivate |
| US7071220B2 (en) | 2000-09-18 | 2006-07-04 | Toa Eiyo Ltd. | N-substituted benzothiophenesulfonamide derivatives |
| EP1640369A4 (de) * | 2003-06-27 | 2007-10-31 | Dainippon Sumitomo Pharma Co | Thiazoliminverbindung und oxazoliminverbindung |
| US7423155B2 (en) | 2003-11-14 | 2008-09-09 | 3M Innovative Properties Company | N-sulfonyldicarboximide containing tethering compounds |
| US7544756B2 (en) | 2005-09-30 | 2009-06-09 | 3M Innovative Properties Company | Crosslinked polymers with amine binding groups |
| MX2008015196A (es) | 2006-05-31 | 2008-12-15 | Asubio Pharma Co Ltd | Compuesto de anillo de 7 miembros, proceso para producir el mismo, y su uso medico. |
| WO2013039985A2 (en) | 2011-09-12 | 2013-03-21 | The Johns Hopkins University | Serine protease inhibitors |
| CA3059458A1 (en) | 2017-05-24 | 2018-11-29 | The University Of Queensland | Novel compounds and uses |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE913473A1 (en) | 1990-10-15 | 1992-04-22 | Fujisawa Pharmaceutical Co | Quinazoline derivatives and their preparation |
| JP2982454B2 (ja) * | 1991-12-20 | 1999-11-22 | 王子製紙株式会社 | 感熱記録体 |
| DE69519921T2 (de) * | 1994-07-29 | 2001-06-13 | Suntory Limited, Osaka | Imidazolidin-derivate und ihre verwendung |
| WO1997011941A1 (fr) * | 1995-09-28 | 1997-04-03 | Suntory Limited | Derives de la quinazoline et leurs emplois |
| AU735545B2 (en) * | 1996-05-24 | 2001-07-12 | Neurosearch A/S | Phenyl derivatives containing an acidic group, their preparation and their use as chloride channel blockers |
-
1999
- 1999-08-20 EP EP99938565A patent/EP1114035B1/de not_active Expired - Lifetime
- 1999-08-20 WO PCT/JP1999/004503 patent/WO2000010982A1/en not_active Ceased
- 1999-08-20 JP JP2000566256A patent/JP2002523404A/ja active Pending
- 1999-08-20 ES ES99938565T patent/ES2259476T3/es not_active Expired - Lifetime
- 1999-08-20 CA CA002341357A patent/CA2341357A1/en not_active Abandoned
- 1999-08-20 US US09/763,213 patent/US6867214B1/en not_active Expired - Fee Related
- 1999-08-20 HU HU0103387A patent/HUP0103387A3/hu unknown
- 1999-08-20 CN CN998111910A patent/CN1216872C/zh not_active Expired - Fee Related
- 1999-08-20 KR KR1020017002168A patent/KR20010089168A/ko not_active Ceased
- 1999-08-20 AU AU53037/99A patent/AU772771B2/en not_active Ceased
- 1999-08-20 DE DE69931378T patent/DE69931378T2/de not_active Expired - Lifetime
- 1999-08-20 AT AT99938565T patent/ATE326451T1/de not_active IP Right Cessation
-
2005
- 2005-03-08 US US11/073,654 patent/US7169951B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP1114035A1 (de) | 2001-07-11 |
| KR20010089168A (ko) | 2001-09-29 |
| US20050148608A1 (en) | 2005-07-07 |
| AU5303799A (en) | 2000-03-14 |
| WO2000010982A1 (en) | 2000-03-02 |
| US6867214B1 (en) | 2005-03-15 |
| US7169951B2 (en) | 2007-01-30 |
| EP1114035B1 (de) | 2006-05-17 |
| HUP0103387A2 (hu) | 2002-04-29 |
| CA2341357A1 (en) | 2000-03-02 |
| CN1216872C (zh) | 2005-08-31 |
| ES2259476T3 (es) | 2006-10-01 |
| JP2002523404A (ja) | 2002-07-30 |
| AU772771B2 (en) | 2004-05-06 |
| CN1319096A (zh) | 2001-10-24 |
| DE69931378T2 (de) | 2006-11-02 |
| DE69931378D1 (de) | 2006-06-22 |
| HUP0103387A3 (en) | 2002-07-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR200200579T2 (tr) | Amino-tirazolpiridin türevleri. | |
| ATE223378T1 (de) | Prolineamid-derivate | |
| TR200200717T2 (tr) | Terapötik kinazolin türevleri. | |
| MXPA04004674A (es) | Ligados de los receptors de los canabinodies. | |
| TW200505902A (en) | Cannabinoid receptor ligands | |
| GEP20053600B (en) | 3-(4-Amidopyrrol-2-Ylmethlidene)-2- Indolinone Derivatives as Protein Kinase Inhibitors | |
| ATE232862T1 (de) | Oxazolidinon derivate und diese enthaltende pharmazeutische zusammensetzungen | |
| TR200201505T2 (tr) | Terapötik maddeler olarak pirazolopirimidinler | |
| BR0109703A (pt) | Derivados de piperazina | |
| GB9914486D0 (en) | Medicaments | |
| BR0210028A (pt) | Agentes antibacterianos | |
| DE60001974D1 (de) | Derivate von flavonen, xanthonen und kumarinen | |
| ECSP055701A (es) | Nuevos derivados de pirimidinamida y el uso de los mismos | |
| SE0101932D0 (sv) | Pharmaceutical combinations | |
| TW200624431A (en) | Phthalazinone derivatives, their manufacture and use as pharmaceutical agents | |
| ATE233754T1 (de) | Diphenyl-piperidin derivate | |
| ATE326451T1 (de) | Chinazolin derivate und therapeutische verwendungen davon | |
| TR199900732T2 (xx) | PDE IV inhibe eden 2-siyanoiminoimidazol t�revleri. | |
| MY133112A (en) | 3-amino-3-arylpropan-1-ol derivatives, and their preparation and use | |
| NO20031410L (no) | Anvendelse av distamycinderivater for fremstilling av medikamenter | |
| SE9901572D0 (sv) | New compounds | |
| TW200510370A (en) | Urea derivatives | |
| WO2004048381A3 (en) | Pyrazoloazepine compounds as pharmaceutical agents | |
| MXPA05010135A (es) | Nuevos derivados de oxazol, procedimiento para su fabricacion y uso como agentes farmaceuticos. | |
| EE200200688A (et) | Akrüloüüldistamütsiini derivaati, mikrotuubulivastast toimeainet ja/või antimetaboliiti sisaldav farmatseutiline kompositsioon, derivaadi kasutamine tuumorivastase ravimi valmistamiseks ning kombineeritud ravimpreparaat |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |